归创通桥医疗科技股份有限公司（股票代码：02190）于2026年4月20日发布公告称，公司当日在香港联交所场内回购48,000股H股，占现有已发行股份约0.0143%。回购价格介乎每股港币23.48元至24.10元，合计涉资约113.93万港元。
本次回购后，公司已发行股份数量降至327,949,613股，库藏股数增至8,401,131股，整体股本总数仍为336,350,744股。公司于2025年5月30日获股东大会批准回购最多31,958,111股，公告显示此前已于市场累计回购5,581,500股，剩余可回购数量为26,376,611股。
公司确认已遵守香港联交所上市规则及相关法例。公告由公司董事赵中签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.